No, we’re not talking about COVID-19 here. But emerging evidence shows a link between the human papillomavirus (HPV) and squamous cell carcinomas of the skin. Viruses may play a role in other skin cancers, too. Here’s what we know so far.
No, we’re not talking about COVID-19 here. But emerging evidence shows a link between the human papillomavirus (HPV) and squamous cell carcinomas of the skin. Viruses may play a role in other skin cancers, too. Here’s what we know so far.
Despite how often CSCC occurs, many Americans don’t seem to know much about it, especially in comparison to melanoma.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
English
Chinese (Simplified)
French
German
Italian
Portuguese
Spanish